Gland Pharma Limited (NSE:GLAND)
1,681.20
+5.30 (0.32%)
Jan 28, 2026, 1:35 PM IST
Gland Pharma Employees
Gland Pharma had 4,351 employees as of March 31, 2025. The number of employees increased by 134 or 3.18% compared to the previous year.
Employees
4,351
Change (1Y)
134
Growth (1Y)
3.18%
Revenue / Employee
13.33M INR
Profits / Employee
1.82M INR
Market Cap
276.12B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2025 | 4,351 | 134 | 3.18% |
| Mar 31, 2024 | 4,217 | -368 | -8.03% |
| Mar 31, 2023 | 4,585 | -54 | -1.16% |
| Mar 31, 2022 | 4,639 | 678 | 17.12% |
| Mar 31, 2021 | 3,961 | 170 | 4.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Ipca Laboratories | 16,778 |
| Alembic Pharmaceuticals | 16,571 |
| Glenmark Pharmaceuticals | 15,800 |
| Ajanta Pharma | 9,628 |
| Emcure Pharmaceuticals | 6,731 |
| Laurus Labs | 6,167 |
| Piramal Pharma | 5,476 |
| NATCO Pharma | 4,199 |
Gland Pharma News
- 19 hours ago - Gland Pharma Ltd (NSE:GLAND) Q3 2026 Earnings Report Preview: What To Expect - GuruFocus
- 5 days ago - Pharma sector stocks today, Jan 23: Dr. Reddy’s Lab jumps 2.14%, Gland Pharma falls 1.71%, Torrent Pharma down 0.80% - Business Upturn
- 20 days ago - Gland Pharma shares surge nearly 4% after getting USFDA approval for Olopatadine Hydrochloride Ophthalmic Solution 0.7% (OTC) - Business Upturn
- 20 days ago - Top stocks to watch today, January 8: Infosys, Tata Steel, HUDCO, Gland Pharma, Angel One, Cipla and more - Business Upturn
- 20 days ago - Gland Pharma receives USFDA approval for Olopatadine Hydrochloride Ophthalmic Solution 0.7% (OTC) - Business Upturn
- 3 months ago - Nomura cautious on Gland Pharma, trims estimates post Q2 miss but sees long-term visibility - Business Upturn
- 3 months ago - Gland Pharma Ltd (NSE:GLAND) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and ... - GuruFocus
- 3 months ago - Q2 2026 Gland Pharma Ltd Earnings Call Transcript - GuruFocus